Clinical and translational findings of pemigatinib in previously treated solid tumors with activating FGFR1-3 alterations in the FIGHT-207 study

Category Primary study
JournalCancer Research
Year 2023
This article has no abstract
Epistemonikos ID: 768d5854aa71497b28a18ca8948f01a8289089a0
First added on: Feb 16, 2025